111 Gross Margin 2018-2024 | YI
Current and historical gross margin for 111 (YI) over the last 10 years. The current gross profit margin for 111 as of December 31, 2024 is %.
| 111 Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $1.97B | $0.11B | 5.78% |
| 2024-09-30 | $2.06B | $0.12B | 5.73% |
| 2024-06-30 | $2.05B | $0.11B | 5.57% |
| 2024-03-31 | $2.06B | $0.11B | 5.54% |
| 2023-12-31 | $2.11B | $0.12B | 5.65% |
| 2023-09-30 | $2.09B | $0.12B | 5.90% |
| 2023-06-30 | $2.05B | $0.13B | 6.09% |
| 2023-03-31 | $2.03B | $0.13B | 6.17% |
| 2022-12-31 | $1.96B | $0.12B | 6.18% |
| 2022-09-30 | $1.96B | $0.12B | 6.12% |
| 2022-06-30 | $2.01B | $0.12B | 5.88% |
| 2022-03-31 | $2.02B | $0.11B | 5.44% |
| 2021-12-31 | $1.95B | $0.10B | 5.03% |
| 2021-09-30 | $1.84B | $0.08B | 4.51% |
| 2021-06-30 | $1.67B | $0.07B | 4.19% |
| 2021-03-31 | $1.43B | $0.06B | 4.26% |
| 2020-12-31 | $1.26B | $0.06B | 4.37% |
| 2020-09-30 | $0.99B | $0.04B | 4.33% |
| 2020-06-30 | $0.80B | $0.04B | 4.62% |
| 2020-03-31 | $0.69B | $0.03B | 4.47% |
| 2019-12-31 | $0.57B | $0.02B | 4.23% |
| 2019-09-30 | $0.45B | $0.02B | 4.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.069B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |